Department of Epidemiology and Biostatistics, University of California San Francisco, United States of America; Department of Pathology and Laboratory Medicine, University of Wisconsin, United States of America.
Department of Psychiatry, University of California San Francisco, United States of America; Kaiser Permanente Center for Health Research, Portland, United States of America.
J Geriatr Oncol. 2023 Jun;14(5):101530. doi: 10.1016/j.jgo.2023.101530. Epub 2023 May 19.
Middle-aged and older adults who develop cancer experience memory loss following diagnosis, but memory decline in the years before and after cancer diagnosis is slower compared to their cancer-free counterparts. Educational attainment strongly predicts memory function during aging, but it is unclear whether education protects against memory loss related to cancer incidence or modifies long-term memory trajectories in middle-aged and older cancer survivors.
Data were from 14,449 adults (3,248 with incident cancer, excluding non-melanoma skin cancer) aged 50+ in the population-based US Health and Retirement Study from 1998 to 2016. Memory was assessed every two years as a composite of immediate and delayed word recall tests and proxy assessments for impaired individuals. Memory scores all time points were standardized at to the baseline distribution. Using multivariate-adjusted linear mixed-effects models, we estimated rates of memory decline in the years before cancer diagnosis, shortly after diagnosis, and in the years after diagnosis. We compared rates of memory decline between incident cancer cases and age-matched cancer-free adults, overall and according to level of education (<12 years, "low"; 12 to <16 years, "intermediate"; ≥16 years, "high").
Incident cancer diagnoses were followed by short-term declines in memory averaging 0.06 standard deviation (SD) units (95% confidence interval [CI]: -0.084, -0.036). Those with low education experienced the strongest magnitude of short-term decline in memory after diagnosis (-0.10 SD units, 95% CI: -0.15, -0.05), but this estimate was not statistically significantly different from the short-term decline in memory experienced by those with high education (-0.04 SD units, 95% CI: -0.08, 0.01; p-value for education as an effect modifier = 0.15). In the years prior to and following an incident cancer diagnosis, higher educational attainment was associated with better memory, but it did not modify the difference in rate of long-term memory decline between cancer survivors and those who remained cancer-free.
Education was associated with better memory function over time among both cancer survivors and cancer-free adults aged 50 and over. Low education may be associated with a stronger short-term decline in memory after a cancer diagnosis.
中年和老年癌症患者在确诊后会出现记忆力下降,但与无癌症对照者相比,他们在癌症诊断前和诊断后的几年内记忆力下降速度较慢。受教育程度强烈预测衰老过程中的记忆功能,但尚不清楚教育是否能预防与癌症发病率相关的记忆力下降,或改变中年和老年癌症幸存者的长期记忆轨迹。
数据来自于参加 1998 年至 2016 年美国健康与退休研究的 14449 名 50 岁以上的成年人(3248 例患有癌症,不包括非黑色素瘤皮肤癌)。每隔两年通过即时和延迟单词回忆测试以及对功能受损个体的代理评估来评估记忆力。所有时间点的记忆评分均标准化至基线分布。我们使用多变量调整的线性混合效应模型,估计了癌症诊断前、诊断后不久和诊断后几年的记忆衰退率。我们比较了癌症病例与年龄匹配的无癌症成年人之间的记忆衰退率,包括整体比较和根据受教育程度(<12 年,“低”;12 至<16 年,“中”;≥16 年,“高”)进行的比较。
癌症确诊后,记忆出现短期下降,平均为 0.06 个标准差单位(95%置信区间:-0.084,-0.036)。受教育程度较低的人在诊断后记忆出现最大程度的短期下降(-0.10 个标准差单位,95%置信区间:-0.15,-0.05),但与受教育程度较高的人(-0.04 个标准差单位,95%置信区间:-0.08,0.01)相比,这一估计值在统计学上无显著差异(检验教育作为效应修饰符的 p 值=0.15)。在癌症确诊前和确诊后几年内,较高的受教育程度与更好的记忆相关,但它并没有改变癌症幸存者和无癌症幸存者之间长期记忆衰退率的差异。
受教育程度与癌症幸存者和 50 岁及以上无癌症成年人的长期记忆功能随时间呈正相关。受教育程度较低可能与癌症诊断后记忆的短期下降幅度较大有关。